Roche’s Virtual Early Drug Development gRED Event 2020 Webcast Replay
Roche has hosted a live video webcast on Tuesday, 18 February 2020.
For optimal viewing, please use Google Chrome
Karl Mahler, Head of Investor Relations and Roche Group Planning
- Overview and Introduction to Genentech (gRED)
Michael Varney, Head of Genentech Research and Early Development
- Non-Oncology Pipeline Overview
Andy Chan, Senior Vice President, Research Biology for gRED
- Oncology Pipeline Overview
Stuart Lutzker, Vice President, Oncology Research and ad interim Head of Early Clinical Development for gRED
- Cancer Immunotherapy
Ira Mellman, Vice President, Cancer Immunology and Immunology for gRED
Please register to access the on-demand webcast.